{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T17:09:41Z","timestamp":1756573781346,"version":"3.37.3"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11102-024-01404-0","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T06:01:53Z","timestamp":1717135313000},"page":"935-944","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Acromegaly and COVID-19, lessons, and new opportunities"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0713-025X","authenticated-orcid":false,"given":"Elena V.","family":"Varlamov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-6289","authenticated-orcid":false,"given":"Maria","family":"Fleseriu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"issue":"11","key":"1404_CR1","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S2213-8587(22)00244-3","volume":"10","author":"M Fleseriu","year":"2022","unstructured":"Fleseriu M, Langlois F, Lim DST, Varlamov EV, Melmed S (2022) Acromegaly: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol 10(11):804\u2013826","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"1404_CR2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1210\/er.2018-00115","volume":"40","author":"MR Gadelha","year":"2019","unstructured":"Gadelha MR, Kasuki L, Lim DST, Fleseriu M (2019) Systemic complications of Acromegaly and the impact of the Current Treatment Landscape: an update. Endocr Rev 40(1):268\u2013332","journal-title":"Endocr Rev"},{"issue":"2","key":"1404_CR3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s11102-021-01198-5","volume":"25","author":"M Fleseriu","year":"2022","unstructured":"Fleseriu M, Barkan A, Del Pilar Schneider M, Darhi Y, de Pierrefeu A, Ribeiro-Oliveira A Jr. et al (2022) Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States. Pituitary 25(2):296\u2013307","journal-title":"Pituitary"},{"issue":"1","key":"1404_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11102-023-01360-1","volume":"27","author":"A Giustina","year":"2024","unstructured":"Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C et al (2024) Consensus on criteria for acromegaly diagnosis and remission. Pituitary 27(1):7\u201322","journal-title":"Pituitary"},{"issue":"6","key":"1404_CR5","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","volume":"43","author":"S Melmed","year":"2022","unstructured":"Melmed S, Kaiser UB, Lopes MB, Bertherat J, Syro LV, Raverot G et al (2022) Clinical Biology of the Pituitary Adenoma. Endocr Rev 43(6):1003\u20131037","journal-title":"Endocr Rev"},{"key":"1404_CR6","doi-asserted-by":"crossref","unstructured":"Fleseriu M, Christ-Crain M, Langlois F, Gadelha M, Melmed S (2024) Hypopituitarism. Lancet. May 9:S0140-6736(24)00342-8. doi: 10.1016\/S0140-6736(24)00342-8","DOI":"10.1016\/S0140-6736(24)00342-8"},{"issue":"5","key":"1404_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s11102-015-0643-8","volume":"18","author":"C Yedinak","year":"2015","unstructured":"Yedinak C, Hameed N, Gassner M, Brzana J, McCartney S, Fleseriu M (2015) Recovery rate of adrenal function after surgery in patients with acromegaly is higher than in those with non-functioning pituitary tumors: a large single center study. Pituitary 18(5):701\u2013709","journal-title":"Pituitary"},{"key":"1404_CR8","doi-asserted-by":"crossref","unstructured":"Giustina A, Barkan A, Beckers A, Biermasz N, Biller BMK, Boguszewski C et al (2020) A Consensus on the diagnosis and treatment of Acromegaly comorbidities: an update. J Clin Endocrinol Metab. ;105(4)","DOI":"10.1210\/clinem\/dgz096"},{"issue":"4","key":"1404_CR9","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11154-020-09588-z","volume":"21","author":"A Giustina","year":"2020","unstructured":"Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B et al (2020) Multidisciplinary management of acromegaly: a consensus. Rev Endocr Metab Disord 21(4):667\u2013678","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"1404_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11102-020-01059-7","volume":"23","author":"M Fleseriu","year":"2020","unstructured":"Fleseriu M, Buchfelder M, Cetas JS, Fazeli PK, Mallea-Gil SM, Gurnell M et al (2020) Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic-an international perspective. Pituitary 23(4):327\u2013337","journal-title":"Pituitary"},{"issue":"1","key":"1404_CR11","doi-asserted-by":"publisher","first-page":"G17","DOI":"10.1530\/EJE-20-0473","volume":"183","author":"M Fleseriu","year":"2020","unstructured":"Fleseriu M, Dekkers OM, Karavitaki N (2020) Endocrinology in the time of COVID-19: management of pituitary tumours. Eur J Endocrinol 183(1):G17\u2013G23","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1404_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41579-023-01001-1","volume":"22","author":"EA Meyerowitz","year":"2024","unstructured":"Meyerowitz EA, Scott J, Richterman A, Male V, Cevik M (2024) Clinical course and management of COVID-19 in the era of widespread population immunity. Nat Rev Microbiol 22(2):75\u201388","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"1404_CR13","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1016\/S2468-2667(23)00078-6","volume":"8","author":"MW Tenforde","year":"2023","unstructured":"Tenforde MW, Link-Gelles R (2023) Reduction in COVID-19-related mortality over time but disparities across population subgroups. Lancet Public Health 8(5):e327\u2013e8","journal-title":"Lancet Public Health"},{"key":"1404_CR14","first-page":"7","volume":"1","author":"S Omboni","year":"2022","unstructured":"Omboni S, Padwal RS, Alessa T, Benczur B, Green BB, Hubbard I et al (2022) The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future. Connect Health 1:7\u201335","journal-title":"Connect Health"},{"issue":"2","key":"1404_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1530\/EJE-21-0216","volume":"185","author":"S Crisafulli","year":"2021","unstructured":"Crisafulli S, Luxi N, Sultana J, Fontana A, Spagnolo F, Giuffrida G et al (2021) Global epidemiology of acromegaly: a systematic review and meta-analysis. Eur J Endocrinol 185(2):251\u2013263","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"1404_CR16","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.eprac.2021.05.005","volume":"27","author":"F Gatto","year":"2021","unstructured":"Gatto F, Khorrami K, Nista F, Corica G, Ferone D (2021) Acromegaly Management in a Tertiary Referral Center after 1 year of the Coronavirus 2019 pandemic: a double challenge. Endocr Pract 27(8):856\u2013857","journal-title":"Endocr Pract"},{"issue":"5","key":"1404_CR17","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s11102-023-01344-1","volume":"26","author":"AN Demir","year":"2023","unstructured":"Demir AN, Sulu C, Kara Z, Sahin S, Ozaydin D, Sonmez O et al (2023) Changing presentation of acromegaly in half a century: a single-center experience. Pituitary 26(5):573\u2013582","journal-title":"Pituitary"},{"issue":"6","key":"1404_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1530\/EJE-20-0019","volume":"182","author":"D Esposito","year":"2020","unstructured":"Esposito D, Ragnarsson O, Johannsson G, Olsson DS (2020) Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality. Eur J Endocrinol 182(6):523\u2013531","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"1404_CR19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11102-012-0447-z","volume":"16","author":"S Siegel","year":"2013","unstructured":"Siegel S, Streetz-van der Werf C, Schott JS, Nolte K, Karges W, Kreitschmann-Andermahr I (2013) Diagnostic delay is associated with psychosocial impairment in acromegaly. Pituitary 16(4):507\u2013514","journal-title":"Pituitary"},{"key":"1404_CR20","unstructured":"Centers for Disease Control and Prevention Background for CDC\u2019s Updated Respiratory Virus Guidance [ https:\/\/www.cdc.gov\/respiratory-viruses\/background\/index.html"},{"issue":"1","key":"1404_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11102-020-01091-7","volume":"24","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Biller BMK, Freda PU, Gadelha MR, Giustina A, Katznelson L et al (2021) A Pituitary Society update to acromegaly management guidelines. Pituitary 24(1):1\u201313","journal-title":"Pituitary"},{"issue":"2","key":"1404_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12020-020-02565-1","volume":"71","author":"A Giustina","year":"2021","unstructured":"Giustina A, Legg E, Cesana BM, Frara S, Mortini P, Fleseriu M (2021) Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era. Endocrine 71(2):273\u2013280","journal-title":"Endocrine"},{"key":"1404_CR23","unstructured":"Khawaja S, Marks M, Gurnell M, Fleseriu M ACROCOVID II: an international survey on acromegaly management more than 1 year into the COVID-19 pandemic era: The 2021 NORD Breakthrough Summit; 2021 [ https:\/\/rarediseases.org\/the-2021-nord-breakthrough-summit\/"},{"issue":"6","key":"1404_CR24","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1111\/coa.13854","volume":"46","author":"SP Williams","year":"2021","unstructured":"Williams SP, Leong SC (2021) One year into the COVID-19 pandemic: what do we know so far from studies assessing risk and mitigation of droplet aerosolisation during endonasal surgery? A systematic review. Clin Otolaryngol 46(6):1368\u20131378","journal-title":"Clin Otolaryngol"},{"issue":"3","key":"1404_CR25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11102-021-01148-1","volume":"24","author":"S Frara","year":"2021","unstructured":"Frara S, Allora A, Castellino L, di Filippo L, Loli P, Giustina A (2021) COVID-19 and the pituitary. Pituitary 24(3):465\u2013481","journal-title":"Pituitary"},{"issue":"3","key":"1404_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s40618-020-01354-x","volume":"44","author":"F Penner","year":"2021","unstructured":"Penner F, Grottoli S, Lanotte MMR, Garbossa D, Zenga F (2021) Pituitary surgery during Covid-19: a first hand experience and evaluation. J Endocrinol Invest 44(3):635\u2013636","journal-title":"J Endocrinol Invest"},{"key":"1404_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jocn.2023.09.010","volume":"117","author":"KQ Liu","year":"2023","unstructured":"Liu KQ, Dallas J, Wenger TA, Ristianto Z, Ding L, Chow F et al (2023) Increased time to surgery and worse perioperative outcome in benign brain tumor patients with COVID-19. J Clin Neurosci 117:20\u201326","journal-title":"J Clin Neurosci"},{"issue":"2","key":"1404_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/ALN.0000000000004809","volume":"140","author":"MF Aziz","year":"2024","unstructured":"Aziz MF, Schenning K, Koike S, O\u2019Glasser A, O\u2019Reilly-Shah VN, Sera V et al (2024) Perioperative Mortality of the COVID-19 recovered patient compared to a Matched Control: a Multicenter Retrospective Cohort Study. Anesthesiology 140(2):195\u2013206","journal-title":"Anesthesiology"},{"key":"1404_CR29","doi-asserted-by":"crossref","unstructured":"SenthilKumar G, Verhagen NB, Nimmer K, Yang X, Figueroa Castro CE, Szabo A et al (2024) Risk of Early Postoperative Cardiovascular and Cerebrovascular Complication in patients with preoperative COVID-19 undergoing Cancer surgery. J Am Coll Surg","DOI":"10.1097\/XCS.0000000000001039"},{"issue":"8","key":"1404_CR30","doi-asserted-by":"publisher","first-page":"915","DOI":"10.4158\/EP-2020-0308","volume":"26","author":"KCJ Yuen","year":"2020","unstructured":"Yuen KCJ, Blevins LS Jr., Findling JW (2020) Important management considerations in patients with Pituitary disorders during the time of the Covid-19 pandemic. Endocr Pract 26(8):915\u2013922","journal-title":"Endocr Pract"},{"key":"1404_CR31","unstructured":"United States Food and Drug Adminsrtation SOMATULINE\u00ae DEPOT (lanreotide) INJECTION Initial U.S. Approval: 2007 2014 [ https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/022074s011lbl.pdf"},{"issue":"1","key":"1404_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11102-022-01285-1","volume":"26","author":"M Fleseriu","year":"2023","unstructured":"Fleseriu M, Zhang Z, Hanman K, Haria K, Houchard A, Khawaja S et al (2023) A systematic literature review to evaluate extended dosing intervals in the pharmacological management of acromegaly. Pituitary 26(1):9\u201341","journal-title":"Pituitary"},{"issue":"12","key":"1404_CR33","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1210\/clinem\/dgad365","volume":"108","author":"M Fleseriu","year":"2023","unstructured":"Fleseriu M, Molitch M, Dreval A, Pokramovich Y, Bondar I, Poteshkin Y et al (2023) MPOWERED Trial Open-label extension: long-term efficacy and Safety data for oral Octreotide capsules in Acromegaly. J Clin Endocrinol Metab 108(12):3214\u20133222","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1404_CR34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10840-021-01033-8","volume":"63","author":"S Gulletta","year":"2022","unstructured":"Gulletta S, Della Bella P, Pannone L, Falasconi G, Cianfanelli L, Altizio S et al (2022) QTc interval prolongation, inflammation, and mortality in patients with COVID-19. J Interv Card Electrophysiol 63(2):441\u2013448","journal-title":"J Interv Card Electrophysiol"},{"issue":"4","key":"1404_CR35","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jjcc.2021.11.019","volume":"79","author":"JA Varney","year":"2022","unstructured":"Varney JA, Dong VS, Tsao T, Sabir MS, Rivera AT, Ghula S et al (2022) COVID-19 and arrhythmia: an overview. J Cardiol 79(4):468\u2013475","journal-title":"J Cardiol"},{"key":"1404_CR36","doi-asserted-by":"publisher","first-page":"656025","DOI":"10.3389\/fendo.2021.656025","volume":"12","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M (2021) Pituitary disorders and COVID-19, Reimagining Care: the pandemic A year and counting. Front Endocrinol (Lausanne) 12:656025","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"1404_CR37","first-page":"863","volume":"66","author":"R de Jesus Nunes","year":"2022","unstructured":"de Jesus Nunes R, Masullo LF, de Fonseca Lira MZR, Leite CMG, Gomes TM, Fontenele EGP et al (2022) Impact of the COVID-19 pandemic in the treatment of patients with acromegaly in a tertiary center: a wake-up call on the importance of telemedicine. Arch Endocrinol Metab 66(6):863\u2013867","journal-title":"Arch Endocrinol Metab"},{"issue":"8","key":"1404_CR38","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1089\/tmj.2020.0579","volume":"27","author":"LA Naves","year":"2021","unstructured":"Naves LA, Rosa IN, Lima TAS, Santana LB, Castro LF, Casulari LA (2021) Implementation and monitoring of a Telemedicine Model in Acromegalic outpatients in a low-income country during the COVID-19 pandemic. Telemed J E Health 27(8):905\u2013914","journal-title":"Telemed J E Health"},{"key":"1404_CR39","first-page":"EP1201","volume":"81","author":"E Filippi","year":"2022","unstructured":"Filippi E, Camerini S, Spinello M, Vettor R, Maffei P, Dassie F (2022) Impact of COVID-19 outbreak on acromegaly patients management. Endocr Abstracts 81:EP1201","journal-title":"Endocr Abstracts"},{"key":"1404_CR40","doi-asserted-by":"crossref","unstructured":"Herman R, Janez A, Goricar K, Rizzo M, Jensterle M (2022) Impact of COVID-19 pandemic on Disease Control Status and Quality of Life of patients with Acromegaly. Med (Kaunas). ;58(12)","DOI":"10.3390\/medicina58121711"},{"issue":"10","key":"1404_CR41","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1210\/clinem\/dgad237","volume":"108","author":"R Pivonello","year":"2023","unstructured":"Pivonello R, Neggers S, Imran SA (2023) Psychopathology in Acromegaly-Real and Perceived. J Clin Endocrinol Metab 108(10):2470\u20132474","journal-title":"J Clin Endocrinol Metab"},{"key":"1404_CR42","first-page":"81P664","volume":"81","author":"SA Pirchio Rosa","year":"2022","unstructured":"Pirchio Rosa SA, Renata C, Valeria G, Federico C, Giulia R, Marta et al (2022) Impact of COVID-19 lockdown in patients with acromegaly: an Italian multicenter experience. Endocr Abstracts 81:81P664","journal-title":"Endocr Abstracts"},{"issue":"4","key":"1404_CR43","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s11102-021-01136-5","volume":"24","author":"E Durcan","year":"2021","unstructured":"Durcan E, Turan S, Sahin S, Sulu C, Taze SS, Kavla Y et al (2021) Psychosocial effects and clinic reflections of the COVID-19 outbreak in patients with acromegaly and Cushing\u2019s disease. Pituitary 24(4):589\u2013599","journal-title":"Pituitary"},{"key":"1404_CR44","unstructured":"Seda Turgut HP, Didem Acarer Bug\u00fcn \u00d6zlem, Karaarslan E, Bozkur N, Pamuk (2022) \u0130lkay \u00c7ak\u0131r, Meral Mert, Sema \u00c7ift\u00e7i Do\u011fan\u015fen. Evaluation of anxiety and perceived stress levels in patients with Acromegaly after the First Lockdown of the Coronavirus Disease 2019 Pandemic. Turkish J Endocrinol Metabolism ;26(2)"},{"key":"1404_CR45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fendo.2017.00040","volume":"8","author":"VJ Geraedts","year":"2017","unstructured":"Geraedts VJ, Andela CD, Stalla GK, Pereira AM, van Furth WR, Sievers C et al (2017) Predictors of quality of life in Acromegaly: no Consensus on biochemical parameters. Front Endocrinol (Lausanne) 8:40","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1404_CR46","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12020-021-02734-w","volume":"72","author":"M Puig-Domingo","year":"2021","unstructured":"Puig-Domingo M, Marazuela M, Yildiz BO, Giustina A (2021) COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology. Endocrine 72(2):301\u2013316","journal-title":"Endocrine"},{"key":"1404_CR47","doi-asserted-by":"publisher","first-page":"101363","DOI":"10.1016\/j.ghir.2020.101363","volume":"56","author":"KCJ Yuen","year":"2021","unstructured":"Yuen KCJ (2021) Growth hormone deficiency, acromegaly and COVID-19: transitioning from media reports to knowledge and a growth hormone hypothesis. Growth Horm IGF Res 56:101363","journal-title":"Growth Horm IGF Res"},{"key":"1404_CR48","unstructured":"Centers for Disease Control and Prevention Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19: Information for Healthcare Professionals [ https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-care\/underlyingconditions.html"},{"issue":"10","key":"1404_CR49","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S2213-8587(20)30271-0","volume":"8","author":"N Holman","year":"2020","unstructured":"Holman N, Knighton P, Kar P, O\u2019Keefe J, Curley M, Weaver A et al (2020) Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol 8(10):823\u2013833","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"1404_CR50","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1530\/EC-20-0361","volume":"9","author":"MR Gadelha","year":"2020","unstructured":"Gadelha MR, Gu F, Bronstein MD, Brue TC, Fleseriu M, Shimon I et al (2020) Risk factors and management of pasireotide-associated hyperglycemia in acromegaly. Endocr Connect 9(12):1178\u20131190","journal-title":"Endocr Connect"},{"issue":"4","key":"1404_CR51","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ecl.2019.08.008","volume":"48","author":"S Puglisi","year":"2019","unstructured":"Puglisi S, Terzolo M (2019) Hypertension and acromegaly. Endocrinol Metab Clin North Am 48(4):779\u2013793","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"17","key":"1404_CR52","doi-asserted-by":"publisher","first-page":"e026143","DOI":"10.1161\/JAHA.122.026143","volume":"11","author":"SR Gnanenthiran","year":"2022","unstructured":"Gnanenthiran SR, Borghi C, Burger D, Caramelli B, Charchar F, Chirinos JA et al (2022) Renin-angiotensin system inhibitors in patients with COVID-19: a Meta-analysis of Randomized controlled trials led by the International Society of Hypertension. J Am Heart Assoc 11(17):e026143","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"1404_CR53","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1001\/jama.2020.25864","volume":"325","author":"RD Lopes","year":"2021","unstructured":"Lopes RD, Macedo AVS, de Barros ESPGM, Moll-Bernardes RJ, Dos Santos TM, Mazza L et al (2021) Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a Randomized Clinical Trial. JAMA 325(3):254\u2013264","journal-title":"JAMA"},{"issue":"12","key":"1404_CR54","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","volume":"126","author":"P Zhang","year":"2020","unstructured":"Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J et al (2020) Association of Inpatient Use of Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res 126(12):1671\u20131681","journal-title":"Circ Res"},{"issue":"3","key":"1404_CR55","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1161\/HYPERTENSIONAHA.120.15289","volume":"76","author":"W Pan","year":"2020","unstructured":"Pan W, Zhang J, Wang M, Ye J, Xu Y, Shen B et al (2020) Clinical features of COVID-19 in patients with essential hypertension and the impacts of renin-angiotensin-aldosterone system inhibitors on the prognosis of COVID-19 patients. Hypertension 76(3):732\u2013741","journal-title":"Hypertension"},{"key":"1404_CR56","doi-asserted-by":"publisher","first-page":"101382","DOI":"10.1016\/j.smrv.2020.101382","volume":"55","author":"MA Miller","year":"2021","unstructured":"Miller MA, Cappuccio FP (2021) A systematic review of COVID-19 and obstructive sleep apnoea. Sleep Med Rev 55:101382","journal-title":"Sleep Med Rev"},{"key":"1404_CR57","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.sleep.2021.03.029","volume":"82","author":"TI Hariyanto","year":"2021","unstructured":"Hariyanto TI, Kurniawan A (2021) Obstructive sleep apnea (OSA) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: a systematic review and meta-analysis. Sleep Med 82:47\u201353","journal-title":"Sleep Med"},{"issue":"4","key":"1404_CR58","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s11102-016-0725-2","volume":"19","author":"A Abreu","year":"2016","unstructured":"Abreu A, Tovar AP, Castellanos R, Valenzuela A, Giraldo CM, Pinedo AC et al (2016) Challenges in the diagnosis and management of acromegaly: a focus on comorbidities. Pituitary 19(4):448\u2013457","journal-title":"Pituitary"},{"issue":"4","key":"1404_CR59","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/cen.12262","volume":"80","author":"J Brzana","year":"2014","unstructured":"Brzana J, Yedinak CG, Hameed N, Fleseriu M (2014) FRAX score in acromegaly: does it tell the whole story? Clin Endocrinol (Oxf) 80(4):614\u2013616","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"1404_CR60","doi-asserted-by":"publisher","first-page":"e2843","DOI":"10.1210\/clinem\/dgac183","volume":"107","author":"S Frara","year":"2022","unstructured":"Frara S, Melin Uygur M, di Filippo L, Doga M, Losa M, Santoro S et al (2022) High prevalence of vertebral fractures Associated with preoperative GH levels in patients with recent diagnosis of Acromegaly. J Clin Endocrinol Metab 107(7):e2843\u2013e50","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1404_CR61","doi-asserted-by":"publisher","first-page":"e602","DOI":"10.1210\/clinem\/dgaa738","volume":"106","author":"L di Filippo","year":"2021","unstructured":"di Filippo L, Formenti AM, Doga M, Pedone E, Rovere-Querini P, Giustina A (2021) Radiological thoracic vertebral fractures are highly prevalent in COVID-19 and predict Disease outcomes. J Clin Endocrinol Metab 106(2):e602\u2013e14","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1404_CR62","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12020-021-02872-1","volume":"74","author":"S Battisti","year":"2021","unstructured":"Battisti S, Napoli N, Pedone C, Lombardi M, Leanza G, Tramontana F et al (2021) Vertebral fractures and mortality risk in hospitalised patients during the COVID-19 pandemic emergency. Endocrine 74(3):461\u2013469","journal-title":"Endocrine"},{"issue":"1","key":"1404_CR63","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1210\/clinem\/dgad493","volume":"109","author":"S Chiloiro","year":"2023","unstructured":"Chiloiro S, Frara S, Gagliardi I, Bianchi A, Giampietro A, Medici M et al (2023) Cholecalciferol Use is Associated with a decreased risk of incident morphometric vertebral fractures in Acromegaly. J Clin Endocrinol Metab 109(1):e58\u2013e68","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1404_CR64","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12020-020-02206-7","volume":"68","author":"MR Ambrosio","year":"2020","unstructured":"Ambrosio MR, Gagliardi I, Chiloiro S, Ferreira AG, Bondanelli M, Giampietro A et al (2020) Acromegaly in the elderly patients. Endocrine 68(1):16\u201331","journal-title":"Endocrine"},{"issue":"4","key":"1404_CR65","doi-asserted-by":"publisher","first-page":"101752","DOI":"10.1016\/j.beem.2023.101752","volume":"37","author":"C Capatina","year":"2023","unstructured":"Capatina C, Poiana C, Fleseriu M (2023) Pituitary and SARS CoV-2: an unremitting conundrum. Best Pract Res Clin Endocrinol Metab 37(4):101752","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"1404_CR66","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/joim.13731","volume":"295","author":"R Bergthorsdottir","year":"2024","unstructured":"Bergthorsdottir R, Esposito D, Olsson DS, Ragnarsson O, Dahlqvist P, Bensing S et al (2024) Increased risk of hospitalization, intensive care and death due to COVID-19 in patients with adrenal insufficiency: a Swedish nationwide study. J Intern Med 295(3):322\u2013330","journal-title":"J Intern Med"},{"key":"1404_CR67","doi-asserted-by":"crossref","unstructured":"Luty J, Hayward L, Jackson M, Duell PB (2021) Severe respiratory failure in a patient with COVID-19 and acromegaly: rapid improvement after adding octreotide. BMJ Case Rep. ;14(8)","DOI":"10.1136\/bcr-2021-243900"},{"issue":"3","key":"1404_CR68","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1210\/jc.2002-020072","volume":"88","author":"A Ben-Shlomo","year":"2003","unstructured":"Ben-Shlomo A, Melmed S (2003) Clinical review 154: the role of pharmacotherapy in perioperative management of patients with acromegaly. J Clin Endocrinol Metab 88(3):963\u2013968","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1404_CR69","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1210\/jc.2012-3072","volume":"98","author":"AK Annamalai","year":"2013","unstructured":"Annamalai AK, Webb A, Kandasamy N, Elkhawad M, Moir S, Khan F et al (2013) A comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy. J Clin Endocrinol Metab 98(3):1040\u20131050","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1404_CR70","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1530\/EJE-17-0872","volume":"178","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Li Q, He W, Qiu H, Ye H, Wang Y et al (2018) The comprehensive impact on human body induced by resolution of growth hormone excess. Eur J Endocrinol 178(4):365\u2013375","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"1404_CR71","doi-asserted-by":"publisher","first-page":"L1064","DOI":"10.1152\/ajplung.00027.2014","volume":"306","author":"C Egger","year":"2014","unstructured":"Egger C, Gerard C, Vidotto N, Accart N, Cannet C, Dunbar A et al (2014) Lung volume quantified by MRI reflects extracellular-matrix deposition and altered pulmonary function in bleomycin models of fibrosis: effects of SOM230. Am J Physiol Lung Cell Mol Physiol 306(12):L1064\u2013L1077","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"1404_CR72","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1183\/09031936.00113011","volume":"39","author":"B Crestani","year":"2012","unstructured":"Crestani B, Chapron J, Wallaert B, Bergot E, Delaval P, Israel-Biet D et al (2012) Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study. Eur Respir J 39(3):772\u2013775","journal-title":"Eur Respir J"},{"issue":"5","key":"1404_CR73","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1507\/endocrj.52.605","volume":"52","author":"Y Taniyama","year":"2005","unstructured":"Taniyama Y, Suzuki T, Mikami Y, Moriya T, Satomi S, Sasano H (2005) Systemic distribution of somatostatin receptor subtypes in human: an immunohistochemical study. Endocr J 52(5):605\u2013611","journal-title":"Endocr J"},{"issue":"8","key":"1404_CR74","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1007\/s40618-023-02016-4","volume":"46","author":"M Ragonese","year":"2023","unstructured":"Ragonese M, Giuffrida G, Alessi Y, Giandalia A, Giovinazzo S, Cotta OR et al (2023) Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing\u2019s disease: a monocentric experience in Southern Italy. J Endocrinol Invest 46(8):1711\u20131715","journal-title":"J Endocrinol Invest"},{"key":"1404_CR75","doi-asserted-by":"publisher","first-page":"232470962110433","DOI":"10.1177\/23247096211043386","volume":"9","author":"N Murvelashvili","year":"2021","unstructured":"Murvelashvili N, Tessnow A (2021) A case of Hypophysitis following immunization with the mRNA-1273 SARS-CoV-2 vaccine. J Investig Med High Impact Case Rep 9:23247096211043386","journal-title":"J Investig Med High Impact Case Rep"},{"key":"1404_CR76","doi-asserted-by":"crossref","unstructured":"Mazzeo P, Ceccato F, Manara R, Mazzon C, Barbot M (2024) Transient Central Diabetes Insipidus (Arginine Vasopressin Deficiency) following SARS-CoV-2 vaccination: a Case Report and Literature Review. Endocr Metab Immune Disord Drug Targets","DOI":"10.2174\/0118715303286560231124115052"},{"key":"1404_CR77","first-page":"EP716","volume":"90","author":"B Sebnem","year":"2023","unstructured":"Uzman Rukiye Dilara Tekin, Sebnem B, Mert DF (2023) Kocak Burak, Hatipoglu Esra Suheda, Niyazoglu Mutlu. Coexistence of acromegaly and Xanthomatous Hypophysitis. Endocr Abstracts 90:EP716","journal-title":"Endocr Abstracts"},{"key":"1404_CR78","first-page":"941738","volume":"2011","author":"JH Martinez","year":"2011","unstructured":"Martinez JH, Davila Martinez M, Mercado de Gorgola M, Montalvo LF, Tome JE (2011) The coexistence of an intrasellar adenoma, lymphocytic hypophysitis, and primary pituitary lymphoma in a patient with acromegaly. Case Rep Endocrinol 2011:941738","journal-title":"Case Rep Endocrinol"},{"issue":"2","key":"1404_CR79","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.4158\/EP161369.CR","volume":"3","author":"A Sharma","year":"2017","unstructured":"Sharma A, K.Richfield E, Lubitz SE (2017) Acromegaly Occurring in a patient with a pituitary adenoma, Lymphocytic Hypophysitis, and a Rathke Cleft Cyst. AACE Clin Case Rep 3(2):e121\u2013e5","journal-title":"AACE Clin Case Rep"},{"issue":"3","key":"1404_CR80","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ecl.2020.05.002","volume":"49","author":"S Fernandes","year":"2020","unstructured":"Fernandes S, Varlamov EV, McCartney S, Fleseriu M (2020) A Novel etiology of Hypophysitis: Immune Checkpoint inhibitors. Endocrinol Metab Clin North Am 49(3):387\u2013399","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"1404_CR81","doi-asserted-by":"publisher","first-page":"101668","DOI":"10.1016\/j.beem.2022.101668","volume":"36","author":"T Mizukoshi","year":"2022","unstructured":"Mizukoshi T, Fukuoka H, Takahashi Y (2022) Immune checkpoint inhibitor-related hypophysitis. Best Pract Res Clin Endocrinol Metab 36(3):101668","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1404_CR82","doi-asserted-by":"crossref","unstructured":"Sabini E, Khan A, Caturegli P, capital ES (2024) Cyrillicytotoxic T lymphocyte-associated protein 4 (CTLA4) is overexpressed in a subset of prolactin- and growth hormone-secreting pituitary adenomas. Endocr Relat Cancer. ;31(1)","DOI":"10.1530\/ERC-23-0196"},{"issue":"6","key":"1404_CR83","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41419-023-05922-w","volume":"14","author":"Y Yang","year":"2023","unstructured":"Yang Y, Xu G (2023) SARS-CoV-2 infection and COVID-19 vaccination in cancer patients undergoing immune checkpoint inhibitors. Cell Death Dis 14(6):390","journal-title":"Cell Death Dis"},{"issue":"2","key":"1404_CR84","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11154-022-09782-1","volume":"24","author":"S Chiloiro","year":"2023","unstructured":"Chiloiro S, De Marinis L (2023) The immune microenviroment in somatotropinomas: from biology to personalized and target therapy. Rev Endocr Metab Disord 24(2):283\u2013295","journal-title":"Rev Endocr Metab Disord"},{"key":"1404_CR85","doi-asserted-by":"crossref","unstructured":"Chiloiro S, Moroni R, Giampietro A, Angelini F, Gessi M, Lauretti L et al (2023) The multi-biomarker acro-TIME score predicts fg-SRLs response: preliminary results of a retrospective acromegaly cohort. J Clin Endocrinol Metab","DOI":"10.1210\/clinem\/dgad673"},{"issue":"2","key":"1404_CR86","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1210\/endrev\/bnac024","volume":"44","author":"MD Ilie","year":"2023","unstructured":"Ilie MD, Vasiljevic A, Bertolino P, Raverot G (2023) Biological and therapeutic implications of the Tumor Microenvironment in Pituitary Adenomas. Endocr Rev 44(2):297\u2013311","journal-title":"Endocr Rev"},{"issue":"3","key":"1404_CR87","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ (2023) Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21(3):133\u2013146","journal-title":"Nat Rev Microbiol"},{"key":"1404_CR88","doi-asserted-by":"publisher","first-page":"102434","DOI":"10.1016\/j.eclinm.2024.102434","volume":"68","author":"S Zhao","year":"2024","unstructured":"Zhao S, Martin EM, Reuken PA, Scholcz A, Ganse-Dumrath A, Srowig A et al (2024) Long COVID is associated with severe cognitive slowing: a multicentre cross-sectional study. EClinicalMedicine 68:102434","journal-title":"EClinicalMedicine"},{"issue":"4","key":"1404_CR89","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s10143-019-01134-z","volume":"43","author":"M Pertichetti","year":"2020","unstructured":"Pertichetti M, Serioli S, Belotti F, Mattavelli D, Schreiber A, Cappelli C et al (2020) Pituitary adenomas and neuropsychological status: a systematic literature review. Neurosurg Rev 43(4):1065\u20131078","journal-title":"Neurosurg Rev"},{"issue":"3","key":"1404_CR90","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s12020-013-0106-9","volume":"46","author":"CG Yedinak","year":"2014","unstructured":"Yedinak CG, Fleseriu M (2014) Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: a pilot study. Endocrine 46(3):585\u2013593","journal-title":"Endocrine"},{"issue":"6","key":"1404_CR91","doi-asserted-by":"publisher","first-page":"938","DOI":"10.20945\/2359-3997000000577","volume":"66","author":"Correction","year":"2022","unstructured":"Correction (2022) Impact of the COVID-19 pandemic in the treatment of patients with acromegaly in a tertiary center: a wake-up call on the importance of telemedicine. Arch Endocrinol Metab 66(6):938","journal-title":"Arch Endocrinol Metab"},{"issue":"10","key":"1404_CR92","doi-asserted-by":"publisher","first-page":"bvad104","DOI":"10.1210\/jendso\/bvad104","volume":"7","author":"M Fleseriu","year":"2023","unstructured":"Fleseriu M, Barkan A, Brue T, Duquesne E, Houchard A, Del Pilar Schneider M et al (2023) Treatment patterns, adherence, persistence, and Health Care Resource Utilization in Acromegaly: a real-world analysis. J Endocr Soc 7(10):bvad104","journal-title":"J Endocr Soc"},{"key":"1404_CR93","doi-asserted-by":"publisher","first-page":"579606","DOI":"10.3389\/fendo.2020.579606","volume":"11","author":"JM Hinojosa-Amaya","year":"2020","unstructured":"Hinojosa-Amaya JM, Johnson N, Gonzalez-Torres C, Varlamov EV, Yedinak CG, McCartney S et al (2020) Depression and Impulsivity Self-Assessment Tools to identify dopamine Agonist Side effects in patients with Pituitary Adenomas. Front Endocrinol (Lausanne) 11:579606","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"1404_CR94","doi-asserted-by":"publisher","first-page":"102910","DOI":"10.1016\/j.arcmed.2023.102910","volume":"54","author":"R Hamblin","year":"2023","unstructured":"Hamblin R, Karavitaki N (2023) Impulse Control disorders in patients with Pituitary Tumors Treated with dopamine agonists: a systematic review. Arch Med Res 54(8):102910","journal-title":"Arch Med Res"},{"issue":"12","key":"1404_CR95","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"S Petersenn","year":"2023","unstructured":"Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BMK et al (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol 19(12):722\u2013740","journal-title":"Nat Rev Endocrinol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01404-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-024-01404-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01404-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T06:18:14Z","timestamp":1733897894000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-024-01404-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":95,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1404"],"URL":"https:\/\/doi.org\/10.1007\/s11102-024-01404-0","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"type":"print","value":"1386-341X"},{"type":"electronic","value":"1573-7403"}],"subject":[],"published":{"date-parts":[[2024,5,31]]},"assertion":[{"value":"17 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MF has received grants to Oregon Health & Science University from Amryt\/Chiesi, Crinetics, Ionis, and Recordati. MF has received occasional consulting fees from Crinetics, Chiesi, Ipsen, and Recordati. MF is in the Editorial Board of Pituitary. EV has received grants to Oregon Health & Science University from Lumiio\/Pfizer and Recordati.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}